Chargement en cours...
MEK and the inhibitors: from bench to bedside
Four distinct MAP kinase signaling pathways involving 7 MEK enzymes have been identified. MEK1 and MEK2 are the prototype members of MEK family proteins. Several MEK inhibitors are in clinical trials. Trametinib is being evaluated by FDA for the treatment of metastatic melanoma with BRAF V600 mutati...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3626705/ https://ncbi.nlm.nih.gov/pubmed/23587417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-27 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|